Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,200
Closed -$7K 8443
2015
Q1
$7K Hold
1,200
﹤0.01% 7883
2014
Q4
$7K Buy
+1,200
New +$7.58K ﹤0.01% 8684

Other funds holding ABEV

UBS Group's ABEV Position: Q2 2026 in Review

UBS Group reduced its Ambev (ABEV) stake by 4.7% in Q2 2026, selling an estimated $958K and leaving 6,243,950 shares worth $19.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2706.

UBS Group first reported a position in ABEV in Q4 2014 and has held it in 47 quarters since. The position peaked at $33.7M in Q1 2025. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • UBS Group held 6,243,950 shares of Ambev worth $19.6M as of Q2 2026.
  • UBS Group sold 306,316 Ambev shares in Q2 2026, an estimated $958K.
  • Ambev made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2706 holding.
  • UBS Group first reported a position in Ambev in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Ambev position peaked at $33.7M in Q1 2025.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.